Arkolith/Insider Trading/CAI/Form 4

Castleman Peter M

DirectorCaris Life Sciences, Inc. (CAI) · full profile →Form 4 · filed Jun 23, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 20, 2025Conversion(C)10.2M—$010.3M
Feb 27, 2025Grant(A)16K—$016K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 20, 2025Conversion(C)41.0M——0
Feb 27, 2025Grant(A)3K—$03K

Transaction Codes

C
Conversion of a derivative
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-061804) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML